{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-006381","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2023-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.147605+00:00","generated_at":"2026-06-16T21:26:05.260837+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aziyo Biologics grants LeMaitre exclusive US distribution rights for cardiovascular products","bullets":["Three-year exclusive US distribution deal for ProxiCor PC, ProxiCor CTR, Tyke, and VasCure.","LeMaitre has an exclusive option to acquire the product line after year one; price based on multiple of trailing 12-month sales.","Initial purchase and minimum purchase volumes start Oct 1, 2023; prices subject to annual adjustment.","Aziyo CEO cites focus on CanGaroo Envelope for implantable electronic devices after this partnership.","LeMaitre President says the deal adds next-gen extracellular matrix patches to its US product offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-006381","json":"https://secwatch.observer/filing/0001558370-23-006381.json","markdown":"https://secwatch.observer/filing/0001558370-23-006381.md","text":"https://secwatch.observer/filing/0001558370-23-006381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/0001558370-23-006381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/azyo-20230420x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:26:05.260837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eb4afdcf8cdec01bba815b67a72ae62755e55947","claim":"ELUTIA INC. entered into Distribution Agreement with LeMaitre Vascular, Inc. (effective 2023-04-20).","evidence_excerpt":"On April 20, 2023, Aziyo Biologics, Inc. (the “Company” or “Aziyo”) entered into a Distribution Agreement (the “Agreement”) with LeMaitre Vascular, Inc., a Delaware corporation (“LeMaitre”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000155837023006381/0001558370-23-006381-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"LeMaitre Vascular, Inc."},{"label":"Effective","value":"2023-04-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}